On Tuesday, Health Catalyst Inc (NASDAQ: HCAT) was -4.21% drop from the session before settling in for the closing price of $5.23. A 52-week range for HCAT has been $5.20 – $9.24.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 17.83% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 108.21%. With a float of $58.54 million, this company’s outstanding shares have now reached $60.85 million.
In an organization with 1300 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 35.68%, operating margin of -21.37%, and the pretax margin is -26.25%.
Health Catalyst Inc (HCAT) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Health Catalyst Inc stocks. The insider ownership of Health Catalyst Inc is 3.79%, while institutional ownership is 89.28%. The most recent insider transaction that took place on Feb 18 ’25, was worth 34,953. In this transaction Chief People Officer of this company sold 6,441 shares at a rate of $5.43, taking the stock ownership to the 85,819 shares. Before that another transaction happened on Feb 18 ’25, when Company’s Officer proposed sale 6,641 for $5.42, making the entire transaction worth $35,994.
Health Catalyst Inc (HCAT) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 108.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 50.80% during the next five years compared to 7.69% growth over the previous five years of trading.
Health Catalyst Inc (NASDAQ: HCAT) Trading Performance Indicators
You can see what Health Catalyst Inc (HCAT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.35, a number that is poised to hit 0.07 in the next quarter and is forecasted to reach 0.37 in one year’s time.
Technical Analysis of Health Catalyst Inc (HCAT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.77 million. That was inferior than the volume of 0.78 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 11.74%. Additionally, its Average True Range was 0.30.
During the past 100 days, Health Catalyst Inc’s (HCAT) raw stochastic average was set at 1.17%, which indicates a significant decrease from 5.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.93% in the past 14 days, which was lower than the 56.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.35, while its 200-day Moving Average is $7.10. However, in the short run, Health Catalyst Inc’s stock first resistance to watch stands at $5.19. Second resistance stands at $5.36. The third major resistance level sits at $5.48. If the price goes on to break the first support level at $4.90, it is likely to go to the next support level at $4.78. The third support level lies at $4.61 if the price breaches the second support level.
Health Catalyst Inc (NASDAQ: HCAT) Key Stats
There are 60,848K outstanding shares of the company, which has a market capitalization of 304.85 million. As of now, sales total 295,940 K while income totals -118,150 K. Its latest quarter income was 76,350 K while its last quarter net income were -14,730 K.
